메뉴 건너뛰기




Volumn 31, Issue 11, 2013, Pages 2109-2117

The unappreciated importance of blood pressure in recent and older atrial fibrillation trials

Author keywords

anticoagulation; apixaban; atrial fibrillation; blood pressure; dabigatran; hypertension; rivaroxaban; vitamin K antagonists; warfarin

Indexed keywords

ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; FIBRINOLYTIC AGENT;

EID: 84885661386     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0b013e3283638194     Document Type: Review
Times cited : (22)

References (66)
  • 1
    • 0346613575 scopus 로고    scopus 로고
    • Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: Population-based estimates
    • Kannel WB, Wolf PA, Benjamin EJ, Levy D. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol 1998; 82:2N-9N.
    • (1998) Am J Cardiol , vol.82
    • Kannel, W.B.1    Wolf, P.A.2    Benjamin, E.J.3    Levy, D.4
  • 2
    • 84855852531 scopus 로고    scopus 로고
    • Hypertension and atrial fibrillation: Diagnostic approach, prevention, and treatment. Position paper of the working group 'Hypertension, Arrhythmias and Thrombosis' of the European Society of Hypertension
    • Manolis AJ, Agabiti-Rosei E, Coca A, Cifkova R, Erdine S, Kjeldsen S, et al. Hypertension and atrial fibrillation: Diagnostic approach, prevention, and treatment. Position paper of the working group 'Hypertension, Arrhythmias and Thrombosis' of the European Society of Hypertension. J Hypertens 2012; 30:239-252.
    • (2012) J Hypertens , vol.30 , pp. 239-252
    • Manolis, A.J.1    Agabiti-Rosei, E.2    Coca, A.3    Cifkova, R.4    Erdine, S.5    Kjeldsen, S.6
  • 4
    • 34250350040 scopus 로고    scopus 로고
    • 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)
    • Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. 2007 Guidelines for the Management of Arterial Hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25:1105-1187.
    • (2007) J Hypertens , vol.25 , pp. 1105-1187
    • Mancia, G.1    De Backer, G.2    Dominiczak, A.3    Cifkova, R.4    Fagard, R.5    Germano, G.6
  • 5
    • 70449851433 scopus 로고    scopus 로고
    • Reappraisal of European guidelines on hypertension management: A European Society of Hypertension Task Force document
    • Mancia G, Laurent S, Agabiti-Rossei E, Ambrosioni E, Burnier M, Caulfield MJ, et al. Reappraisal of European guidelines on hypertension management: A European Society of Hypertension Task Force document. J Hypertens 2009; 27:2121-2158.
    • (2009) J Hypertens , vol.27 , pp. 2121-2158
    • Mancia, G.1    Laurent, S.2    Agabiti-Rossei, E.3    Ambrosioni, E.4    Burnier, M.5    Caulfield, M.J.6
  • 6
    • 0037079309 scopus 로고    scopus 로고
    • Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies
    • Prospective Studies Collaboration
    • Lewington S, Clarke R, Qizilbash N, Peto R, Collins R, Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360:1903-1913.
    • (2002) Lancet , vol.360 , pp. 1903-1913
    • Lewington, S.1    Clarke, R.2    Qizilbash, N.3    Peto, R.4    Collins, R.5
  • 7
    • 0027472583 scopus 로고
    • Ischemic stroke in patients with atrial fibrillation: Effect of aspirin according to stroke mechanism
    • on behalf of the SPAF Investigators
    • Miller VT, Rothrock JF, Pearce LA, Feinberg WM, Hart RG, Anderson DC, on behalf of the SPAF Investigators. Ischemic stroke in patients with atrial fibrillation: effect of aspirin according to stroke mechanism. Neurology 1993; 43:32-36.
    • (1993) Neurology , vol.43 , pp. 32-36
    • Miller, V.T.1    Rothrock, J.F.2    Pearce, L.A.3    Feinberg, W.M.4    Hart, R.G.5    Anderson, D.C.6
  • 8
    • 85007177383 scopus 로고
    • Risk factors for thromboembolism during aspirin therapy in patients with atrial fibrillation: The Stroke Prevention in Atrial Fibrillation Study
    • SPAF Investigators
    • SPAF Investigators. Risk factors for thromboembolism during aspirin therapy in patients with atrial fibrillation: the Stroke Prevention in Atrial Fibrillation Study. J Stroke Cerebrovasc Dis 1995; 5:147-157.
    • (1995) J Stroke Cerebrovasc Dis , vol.5 , pp. 147-157
  • 9
    • 0033063754 scopus 로고    scopus 로고
    • Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation: Analysis of 2012 participants in the SPAF I-III Clinical Trials
    • on behalf of the SPAF Investigators
    • Hart RG, Pearce LA, McBride R, Rothbart RM, Asinger RW, on behalf of the SPAF Investigators. Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation: Analysis of 2012 participants in the SPAF I-III Clinical Trials. Stroke 1999; 30:1223-1229.
    • (1999) Stroke , vol.30 , pp. 1223-1229
    • Hart, R.G.1    Pearce, L.A.2    McBride, R.3    Rothbart, R.M.4    Asinger, R.W.5
  • 10
    • 0042422040 scopus 로고    scopus 로고
    • A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: The Framingham Heart Study
    • Wang TJ, Massaro JM, Levy D, Vasan RS, Wolf PA, D'Agostino RB, et al. A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study. JAMA 2003; 290:1049-1056.
    • (2003) JAMA , vol.290 , pp. 1049-1056
    • Wang, T.J.1    Massaro, J.M.2    Levy, D.3    Vasan, R.S.4    Wolf, P.A.5    D'Agostino, R.B.6
  • 11
    • 76549179893 scopus 로고
    • Systemic embolism and anticoagulant prophylaxis in rheumatic heart disease
    • Szekely P. Systemic embolism and anticoagulant prophylaxis in rheumatic heart disease. BMJ 1964; 5392:1209-1212.
    • (1964) BMJ , vol.5392 , pp. 1209-1212
    • Szekely, P.1
  • 12
    • 34248151980 scopus 로고    scopus 로고
    • Management of atrial fibrillation
    • Lip GY, Tse HF. Management of atrial fibrillation. Lancet 2012; 370:604-618.
    • (2012) Lancet , vol.370 , pp. 604-618
    • Lip, G.Y.1    Tse, H.F.2
  • 13
    • 0033527355 scopus 로고    scopus 로고
    • Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: A meta-analysis
    • Hart RG, Benavente O, McBride R, Pearce LA. Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: A meta-analysis. Ann Intern Med 1999; 131:492-501.
    • (1999) Ann Intern Med , vol.131 , pp. 492-501
    • Hart, R.G.1    Benavente, O.2    McBride, R.3    Pearce, L.A.4
  • 14
    • 0028244264 scopus 로고
    • Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation
    • Atrial Fibrillation Investigators
    • Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med 1994; 154:1449-1457.
    • (1994) Analysis of Pooled Data from Five Randomized Controlled Trials. Arch Intern Med , vol.154 , pp. 1449-1457
  • 15
    • 4644230820 scopus 로고    scopus 로고
    • The pharmacology and management of the vitamin K antagonists: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
    • Ansell J, Hirsh J, Poller L, Bussey H, Jacobson A, Hylek E. The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126 (suppl):204S-233S.
    • (2004) Chest , vol.126 , Issue.SUPPL.
    • Ansell, J.1    Hirsh, J.2    Poller, L.3    Bussey, H.4    Jacobson, A.5    Hylek, E.6
  • 16
    • 33645826019 scopus 로고    scopus 로고
    • Use and effectiveness of warfarin in Medicare beneficiaries with atrial fibrillation
    • Birman-Deych ERM, Nilasena DS, Gage BF. Use and effectiveness of warfarin in Medicare beneficiaries with atrial fibrillation. Stroke 2006; 37:1070-1074.
    • (2006) Stroke , vol.37 , pp. 1070-1074
    • Birman-Deych, E.R.M.1    Nilasena, D.S.2    Gage, B.F.3
  • 17
    • 0242654867 scopus 로고    scopus 로고
    • Effects of different blood-pressure-lowering regimens on major cardiovascular events: Results of prospectively designed overviews of randomized trials
    • Blood Pressure Lowering Treatment Trialists' Collaboration
    • Turnbull F, Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively designed overviews of randomized trials. Lancet 2003; 362:1527-1535.
    • (2003) Lancet , vol.362 , pp. 1527-1535
    • Turnbull, F.1
  • 18
    • 79958769725 scopus 로고    scopus 로고
    • Effects of intensive blood pressure reduction on myocardial infarction and stroke in diabetes: A meta-analysis in 73913 patients
    • Reboldi G, Gentile G, Angeli F, Ambrosio G, Mancia G, Verdecchia P. Effects of intensive blood pressure reduction on myocardial infarction and stroke in diabetes: A meta-analysis in 73913 patients. J Hypertens 2011; 29:1253-1269.
    • (2011) J Hypertens , vol.29 , pp. 1253-1269
    • Reboldi, G.1    Gentile, G.2    Angeli, F.3    Ambrosio, G.4    Mancia, G.5    Verdecchia, P.6
  • 19
    • 0028306578 scopus 로고
    • Blood pressure, antihypertensive drug treatment and the risk of stroke and of coronary heart disease
    • Collins R, MacMahon S. Blood pressure, antihypertensive drug treatment and the risk of stroke and of coronary heart disease. Br Med Bull 1994; 50:272-298.
    • (1994) Br Med Bull , vol.50 , pp. 272-298
    • Collins, R.1    Macmahon, S.2
  • 20
    • 33646829274 scopus 로고    scopus 로고
    • Lower target blood pressures are safe and effective for the prevention of recurrent stroke: The PROGRESS trial
    • Arima H, Chalmers J, Woodward M, Anderson C, Rodgers A, Davis S, et al. Lower target blood pressures are safe and effective for the prevention of recurrent stroke: the PROGRESS trial. J Hypertens 2006; 24:1201-1208.
    • (2006) J Hypertens , vol.24 , pp. 1201-1208
    • Arima, H.1    Chalmers, J.2    Woodward, M.3    Anderson, C.4    Rodgers, A.5    Davis, S.6
  • 21
    • 0035968623 scopus 로고    scopus 로고
    • Randomised trial of a perindoprilbased blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack
    • Progress Collaborative Group
    • PROGRESS Collaborative Group. Randomised trial of a perindoprilbased blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet 2001; 358:1033-1041.
    • (2001) Lancet , vol.358 , pp. 1033-1041
  • 23
    • 78751623197 scopus 로고    scopus 로고
    • 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (Updating the 2006 Guideline): A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
    • 2011 Writing Group Members, 2006 Writing Committee Members, ACCF/AHA Task Force Members
    • Wann LS, Curtis AB, January CT, Ellenbogen KA, Lowe JE, Estes NA 3rd, et al. 2011 Writing Group Members, 2006 Writing Committee Members, ACCF/AHA Task Force Members. 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (Updating the 2006 Guideline): A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2011; 123:104-123.
    • (2011) Circulation , vol.123 , pp. 104-123
    • Wann, L.S.1    Curtis, A.B.2    January, C.T.3    Ellenbogen, K.A.4    Lowe, J.E.5    Estes III, N.A.6
  • 24
    • 79953066921 scopus 로고    scopus 로고
    • 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on dabigatran). A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
    • American College of Cardiology Foundation/American Heart Association Task Force
    • Wann LS, Lowe JE, Page RL, Slotwiner DJ, Stevenson WG, Tracy CM, et al. American College of Cardiology Foundation/American Heart Association Task Force. 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on dabigatran). A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2011; 123:1144-1150.
    • (2011) Circulation , vol.123 , pp. 1144-1150
    • Wann, L.S.1    Lowe, J.E.2    Page, R.L.3    Slotwiner, D.J.4    Stevenson, W.G.5    Tracy, C.M.6
  • 25
    • 84856745317 scopus 로고    scopus 로고
    • Antithrombotic Therapy for Atrial Fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th Ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
    • American College of Chest Physicians
    • You JJ, Singer DE, Howard PA, Lane DA, Eckman MH, Fang MC, et al. American College of Chest Physicians. Antithrombotic therapy for atrial fibrillation: Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141:e531S-e575S.
    • (2012) Chest , vol.141
    • You, J.J.1    Singer, D.E.2    Howard, P.A.3    Lane, D.A.4    Eckman, M.H.5    Fang, M.C.6
  • 26
    • 84858595913 scopus 로고    scopus 로고
    • Focused 2012 Update of the Canadian Cardiovascular Society Atrial fibrillation Guidelines: Recommendations for stroke prevention and rate/rhythm control
    • Canadian Cardiovascular Society Atrial Fibrillation Guidelines Committee
    • Skanes AC, Healey JS, Cairns JA, Dorian P, Gillis AM, McMurtry MS, et al. Canadian Cardiovascular Society Atrial Fibrillation Guidelines Committee. Focused 2012 Update of the Canadian Cardiovascular Society Atrial fibrillation Guidelines: recommendations for stroke prevention and rate/rhythm control. Can J Cardiol 2012; 28:125-136.
    • (2012) Can J Cardiol , vol.28 , pp. 125-136
    • Skanes, A.C.1    Healey, J.S.2    Cairns, J.A.3    Dorian, P.4    Gillis, A.M.5    McMurtry, M.S.6
  • 31
    • 0345414673 scopus 로고    scopus 로고
    • Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with nonvalvular atrial fibrillation
    • Executive Steering Committee for the SPORTIF III Investigators
    • Olsson SB, Executive Steering Committee for the SPORTIF III Investigators. Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with nonvalvular atrial fibrillation. Lancet 2003; 362:1691-1698.
    • (2003) Lancet , vol.362 , pp. 1691-1698
    • Olsson, S.B.1
  • 32
    • 13444309949 scopus 로고    scopus 로고
    • Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: A randomized trial
    • Albers GW, Diener HC, Frison L, Grind M, Nevinson M, Partridge S, et al. Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: A randomized trial. JAMA 2005; 293:690-698.
    • (2005) JAMA , vol.293 , pp. 690-698
    • Albers, G.W.1    Diener, H.C.2    Frison, L.3    Grind, M.4    Nevinson, M.5    Partridge, S.6
  • 33
    • 84856842909 scopus 로고    scopus 로고
    • Apixaban versus aspirin in patients with atrial fibrillation and previous stroke or transient ischemic attack: A predefined subgroup analysis from AVERROES, a randomized trial
    • Diener HC, Eikelboom J, Conolly SJ, Joyner CD, Hart RG, Lip GY, et al. Apixaban versus aspirin in patients with atrial fibrillation and previous stroke or transient ischemic attack: A predefined subgroup analysis from AVERROES, a randomized trial. Lancet Neurol 2012; 11:225-231.
    • (2012) Lancet Neurol , vol.11 , pp. 225-231
    • Diener, H.C.1    Eikelboom, J.2    Conolly, S.J.3    Joyner, C.D.4    Hart, R.G.5    Lip, G.Y.6
  • 34
    • 9544248668 scopus 로고    scopus 로고
    • Adjusted dose warfarin versus low-intensity, fixed dose warfarin plus aspirin for high risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomized clinical trial
    • SPAF III Investigators.
    • SPAF III Investigators. Adjusted dose warfarin versus low-intensity, fixed dose warfarin plus aspirin for high risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomized clinical trial. Lancet 1996; 348:633-638.
    • (1996) Lancet , vol.348 , pp. 633-638
  • 37
    • 0031852543 scopus 로고    scopus 로고
    • Fixed minidose warfarin and aspirin alone and in combination versus adjusted-dose warfarin for stroke prevention in atrial fibrillation
    • Gullov AL, Koefed B, Petersen P, Pedersen TS, Andersen ED, Godtfredsen J, et al. Fixed minidose warfarin and aspirin alone and in combination versus adjusted-dose warfarin for stroke prevention in atrial fibrillation. Arch Intern Med 1998; 158:1513-1521.
    • (1998) Arch Intern Med , vol.158 , pp. 1513-1521
    • Gullov, A.L.1    Koefed, B.2    Petersen, P.3    Pedersen, T.S.4    Andersen, E.D.5    Godtfredsen, J.6
  • 38
    • 0033539341 scopus 로고    scopus 로고
    • Primary prevention of arterial thromboembolism in nonrheumatic atrial fibrillation in primary care: Randomized controlled trial comparing two intensities of coumarin and aspirin
    • Hellemons B, Langenberg M, Lodder J, Vermeer F, Schouten HJ, Lemmens T, et al. Primary prevention of arterial thromboembolism in nonrheumatic atrial fibrillation in primary care: randomized controlled trial comparing two intensities of coumarin and aspirin. BMJ 1999; 319:958-964.
    • (1999) BMJ , vol.319 , pp. 958-964
    • Hellemons, B.1    Langenberg, M.2    Lodder, J.3    Vermeer, F.4    Schouten, H.J.5    Lemmens, T.6
  • 39
    • 0031817074 scopus 로고    scopus 로고
    • Effectiveness of fixed minidose warfarin in the prevention of thromboembolism and vascular death in nonrheumatic atrial fibrillation
    • Pengo V, Zasso A, Barbero F, Banzato A, Nante G, Parissenti L, et al. Effectiveness of fixed minidose warfarin in the prevention of thromboembolism and vascular death in nonrheumatic atrial fibrillation. Am J Cardiol 1998; 82:433-437.
    • (1998) Am J Cardiol , vol.82 , pp. 433-437
    • Pengo, V.1    Zasso, A.2    Barbero, F.3    Banzato, A.4    Nante, G.5    Parissenti, L.6
  • 40
    • 0034036322 scopus 로고    scopus 로고
    • Optimal intensity of warfarin therapy for secondary prevention of stroke in patients with nonvalvular atrial fibrillation
    • Yamaguchi T. Optimal intensity of warfarin therapy for secondary prevention of stroke in patients with nonvalvular atrial fibrillation. Stroke 2000; 31:817-821.
    • (2000) Stroke , vol.31 , pp. 817-821
    • Yamaguchi, T.1
  • 41
    • 0025914693 scopus 로고
    • Stroke Prevention in Atrial Fibrillation Study. Final results
    • Stroke Prevention in Atrial Fibrillation Investigators
    • Stroke Prevention in Atrial Fibrillation Investigators. Stroke Prevention in Atrial Fibrillation Study. Final results. Circulation 1991; 84:527-539.
    • (1991) Circulation , vol.84 , pp. 527-539
  • 42
    • 34547693119 scopus 로고    scopus 로고
    • Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): A randomized, controlled trial
    • Mant J, Hobbs FD, Fletcher K, Roalfe A, Fitzmaurice D, Lip GY, et al. Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): A randomized, controlled trial. Lancet 2007; 370:493-503.
    • (2007) Lancet , vol.370 , pp. 493-503
    • Mant, J.1    Hobbs, F.D.2    Fletcher, K.3    Roalfe, A.4    Fitzmaurice, D.5    Lip, G.Y.6
  • 44
    • 0037028033 scopus 로고    scopus 로고
    • A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation
    • van Gelder I, Hagens VE, Bosker HA, Kingma JH, Kamp O, Kingma T, et al. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 2002; 347:1834-1840.
    • (2002) N Engl J Med , vol.347 , pp. 1834-1840
    • Van Gelder, I.1    Hagens, V.E.2    Bosker, H.A.3    Kingma, J.H.4    Kamp, O.5    Kingma, T.6
  • 46
    • 0034715973 scopus 로고    scopus 로고
    • Rhythm or rate control in atrial fibrillation: Pharmacological Intervention in Atrial Fibrillation (PIAF) -A randomised trial
    • Hohnloser SH, Kuck KH, Lilienthal J. Rhythm or rate control in atrial fibrillation: Pharmacological Intervention in Atrial Fibrillation (PIAF) -a randomised trial. Lancet 2000; 356:1789-1794.
    • (2000) Lancet , vol.356 , pp. 1789-1794
    • Hohnloser, S.H.1    Kuck, K.H.2    Lilienthal, J.3
  • 47
    • 0038025290 scopus 로고    scopus 로고
    • Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: The Strategies of Treatment of Atrial Fibrillation (STAF) study
    • Carlsson J, Miketic S, Windeler J, Cuneo A, Haun S, Micus S, et al. Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study. J Am Coll Cardiol 2003; 41:1690-1696.
    • (2003) J Am Coll Cardiol , vol.41 , pp. 1690-1696
    • Carlsson, J.1    Miketic, S.2    Windeler, J.3    Cuneo, A.4    Haun, S.5    Micus, S.6
  • 48
    • 4143064759 scopus 로고    scopus 로고
    • Rate control vs rhythm control in patients with nonvalvular persistent atrial fibrillation: The results of the Polish How to Treat Chronic Atrial Fibrillation (HOT CAFE) Study
    • Opolski G, Torbicki A, Kosior DA, Szulc M, Wozakowska-Kaplon B, Kolodziej P, Achremczyk P. Rate control vs rhythm control in patients with nonvalvular persistent atrial fibrillation: the results of the Polish How to Treat Chronic Atrial Fibrillation (HOT CAFE) Study. Chest 2004; 126:476-486.
    • (2004) Chest , vol.126 , pp. 476-486
    • Opolski, G.1    Torbicki, A.2    Kosior, D.A.3    Szulc, M.4    Wozakowska-Kaplon, B.5    Kolodziej, P.6    Achremczyk, P.7
  • 49
    • 0025347391 scopus 로고
    • Blood pressure, stroke, and coronary heart disease. Part 2. Shortterm reduction in blood pressure: Overview of randomized drug trials in their epidemiological context
    • Collins R, Peto R, MacMahon S, Hebert P, Fiebach NH, Eberlein KA, et al. Blood pressure, stroke, and coronary heart disease. Part 2. Shortterm reduction in blood pressure: overview of randomized drug trials in their epidemiological context. Lancet 1990; 335:827-838.
    • (1990) Lancet , vol.335 , pp. 827-838
    • Collins, R.1    Peto, R.2    Macmahon, S.3    Hebert, P.4    Fiebach, N.H.5    Eberlein, K.A.6
  • 50
    • 77951735232 scopus 로고    scopus 로고
    • Effects of intensive blood pressure control in type 2 diabetes mellitus
    • for the ACCORD study group
    • Cushman C, Evans G, Byington R, for the ACCORD study group. Effects of intensive blood pressure control in type 2 diabetes mellitus. N Engl J Med 2010; 362:1575-1585.
    • (2010) N Engl J Med , vol.362 , pp. 1575-1585
    • Cushman, C.1    Evans, G.2    Byington, R.3
  • 51
    • 80054959783 scopus 로고    scopus 로고
    • Blood pressure targets recommended by guidelines and incidence of cardiovascular and renal events in the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial (ONTARGET)
    • Mancia G, Schumacher H, Redon J, Verdecchia P, Schmieder R, Jennings G, et al. Blood pressure targets recommended by guidelines and incidence of cardiovascular and renal events in the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial (ONTARGET). Circulation 2011; 124:1727-1736.
    • (2011) Circulation , vol.124 , pp. 1727-1736
    • Mancia, G.1    Schumacher, H.2    Redon, J.3    Verdecchia, P.4    Schmieder, R.5    Jennings, G.6
  • 54
    • 34047206571 scopus 로고    scopus 로고
    • Using public health indicators to measure the success of hypertension control
    • Cooper RS. Using public health indicators to measure the success of hypertension control. Hypertension 2007; 49:773-774.
    • (2007) Hypertension , vol.49 , pp. 773-774
    • Cooper, R.S.1
  • 55
    • 26444553309 scopus 로고    scopus 로고
    • Perindopril-based blood pressure lowering reduces major vascular events in patients with atrial fibrillation and prior stroke or transient ischemic attack
    • Arima H, Hart RG, Colman S, Chalmers J, Anderson C, Rodgers A, et al. Perindopril-based blood pressure lowering reduces major vascular events in patients with atrial fibrillation and prior stroke or transient ischemic attack. Stroke 2005; 36:2164-2169.
    • (2005) Stroke , vol.36 , pp. 2164-2169
    • Arima, H.1    Hart, R.G.2    Colman, S.3    Chalmers, J.4    Anderson, C.5    Rodgers, A.6
  • 56
    • 55749115770 scopus 로고    scopus 로고
    • Disparate stroke rates on warfarin among contemporaneous cohorts with atrial fibrillation
    • Hylek E, Frison L, Henault L, Cupples A. Disparate stroke rates on warfarin among contemporaneous cohorts with atrial fibrillation. Stroke 2008; 39:3009-3014.
    • (2008) Stroke , vol.39 , pp. 3009-3014
    • Hylek, E.1    Frison, L.2    Henault, L.3    Cupples, A.4
  • 57
    • 33947307931 scopus 로고    scopus 로고
    • Effect of hypertension on anticoagulated patients with atrial fibrillation
    • Lip GY, Frison L, Grind M. Effect of hypertension on anticoagulated patients with atrial fibrillation. Eur Heart J 2007; 28:752-759.
    • (2007) Eur Heart J , vol.28 , pp. 752-759
    • Lip, G.Y.1    Frison, L.2    Grind, M.3
  • 58
    • 84861616750 scopus 로고    scopus 로고
    • Intracranial hemorrhage in atrial fibrillation patients during anticoagulation with warfarin or dabigatran
    • Hart RG, Diener HC, Yang C, Connoly SJ, Wallentin L, Reilly P, et al. Intracranial hemorrhage in atrial fibrillation patients during anticoagulation with warfarin or dabigatran. The RE-LY trial. Stroke 2012; 43:1511-1517.
    • (2012) The RE-LY Trial. Stroke , vol.43 , pp. 1511-1517
    • Hart, R.G.1    Diener, H.C.2    Yang, C.3    Connoly, S.J.4    Wallentin, L.5    Reilly, P.6
  • 59
    • 22044452252 scopus 로고    scopus 로고
    • Avoiding central nervous system bleeding during antithrombotic therapy: Recent data and ideas
    • Hart RG, Tonarelli SB, Pearce LA. Avoiding central nervous system bleeding during antithrombotic therapy: recent data and ideas. Stroke 2005; 36:1588-1593.
    • (2005) Stroke , vol.36 , pp. 1588-1593
    • Hart, R.G.1    Tonarelli, S.B.2    Pearce, L.A.3
  • 60
    • 66049146981 scopus 로고    scopus 로고
    • Pharmacotherapy for the secondary prevention of stroke
    • Toyoda K. Pharmacotherapy for the secondary prevention of stroke. Drugs 2009; 69:633-647.
    • (2009) Drugs , vol.69 , pp. 633-647
    • Toyoda, K.1
  • 61
    • 84861648567 scopus 로고    scopus 로고
    • Effects of blood pressure lowering on intracranial and extracranial bleeding in patients on antithrombotic therapy
    • Arima H, Anderson C, Omae T, Woodward M, MacMahon S, Mancia G, et al. Effects of blood pressure lowering on intracranial and extracranial bleeding in patients on antithrombotic therapy. The PROGRESS trial. Stroke 2012; 43:1675-1677.
    • (2012) The PROGRESS Trial. Stroke , vol.43 , pp. 1675-1677
    • Arima, H.1    Anderson, C.2    Omae, T.3    Woodward, M.4    Macmahon, S.5    Mancia, G.6
  • 63
    • 9044251599 scopus 로고    scopus 로고
    • Bleeding during antithrombotic therapy in atrial fibrillation
    • Stroke Prevention in Atrial Fibrillation Investigators.
    • Stroke Prevention in Atrial Fibrillation Investigators. Bleeding during antithrombotic therapy in atrial fibrillation. Arch Intern Med 1996; 156:409-416.
    • (1996) Arch Intern Med , vol.156 , pp. 409-416
  • 64
    • 0032862352 scopus 로고    scopus 로고
    • Major bleeding during anticoagulation after cerebral ischemia. Patterns and risk factors
    • for the Stroke Prevention In Reversible Ischemia Trial (SPIRIT), and European Atrial Fibrillation Trial (EAFT) Study Groups
    • Gorter JW, for the Stroke Prevention In Reversible Ischemia Trial (SPIRIT), and European Atrial Fibrillation Trial (EAFT) Study Groups. Major bleeding during anticoagulation after cerebral ischemia. Patterns and risk factors. Neurology 1999; 53:1319-1327.
    • (1999) Neurology , vol.53 , pp. 1319-1327
    • Gorter, J.W.1
  • 65
    • 33745250499 scopus 로고    scopus 로고
    • Stroke prevention in patients with atrial fibrillation: The diagnosis and management of hypertension by specialists
    • Healey J, Wharton S, Al-Kaabi S, Pai M, Ravandi A, Nair G, et al. Stroke prevention in patients with atrial fibrillation: the diagnosis and management of hypertension by specialists. Can J Cardiol 2006; 22:485-488.
    • (2006) Can J Cardiol , vol.22 , pp. 485-488
    • Healey, J.1    Wharton, S.2    Al-Kaabi, S.3    Pai, M.4    Ravandi, A.5    Nair, G.6
  • 66
    • 84858709300 scopus 로고    scopus 로고
    • Feasibility and safety of dabigatran versus warfarin for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation
    • Lakkireddy D, Reddy Y, Di Biase L, Vanga SR, Santangeli P, Swarup V, et al. Feasibility and safety of dabigatran versus warfarin for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation. J Am Coll Cardiol 2012; 59:1168-1174.
    • (2012) J Am Coll Cardiol , vol.59 , pp. 1168-1174
    • Lakkireddy, D.1    Reddy, Y.2    Di Biase, L.3    Vanga, S.R.4    Santangeli, P.5    Swarup, V.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.